115 related articles for article (PubMed ID: 11249919)
21. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
Ni LF; Liu XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
[TBL] [Abstract][Full Text] [Related]
22. CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers.
Charalabopoulos K; Karakosta A; Bablekos G; Golias C; Charalabopoulos A; Tsanou E; Peschos D; Zoganas L; Batistatou A
Med Oncol; 2007; 24(2):219-25. PubMed ID: 17848747
[TBL] [Abstract][Full Text] [Related]
23. The concentrations of five tumor markers in both BAL fractions in lung cancer patients in relation to cigarette smoking.
Pardos MC; Alvarez-Sala R; Terreros Caro FJ; Gómez L; Gómez de Terreros FJ; Villamor J
Tumori; 1999; 85(6):454-7. PubMed ID: 10774565
[TBL] [Abstract][Full Text] [Related]
24. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer.
Załeska J; Pirozynski M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():179-89. PubMed ID: 9337536
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
[TBL] [Abstract][Full Text] [Related]
26. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
28. Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer.
Sanguinetti CM; Riccioni G; Marchesani F; Pela R; Cecarini L
Monaldi Arch Chest Dis; 1995 May; 50(3):177-82. PubMed ID: 7663486
[TBL] [Abstract][Full Text] [Related]
29. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
30. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Yang Q; Zhang P; Wu R; Lu K; Zhou H
Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
[TBL] [Abstract][Full Text] [Related]
31. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of albumin in bronchial washing fluid of patients with bronchial carcinoma. Could albumin be considered as a tumor marker?
Charokopos N; Leotsinidis M; Tsiamita M; Kalofonos HP; Vasillakos P; Christofidou M; Spiropoulos K
Int J Biol Markers; 2004; 19(4):316-21. PubMed ID: 15646839
[TBL] [Abstract][Full Text] [Related]
33. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
34. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients.
Prados C; Alvarez-Sala R; Gómez de Terrero J; Callol L; García Río F; Gómez Carrera L; Gomez de Terreros Caro J; Alvarez-Sala JL; Espinós D; Villamor J
Jpn J Clin Oncol; 2000 May; 30(5):215-20. PubMed ID: 10857498
[TBL] [Abstract][Full Text] [Related]
36. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
Zheng H; He BF; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
[TBL] [Abstract][Full Text] [Related]
38. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
40. Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer.
Fiorelli A; Rizzo A; Messina G; Izzo A; Vicidomini G; Pannone G; Santini M; Di Domenico M
Eur J Cardiothorac Surg; 2012 Apr; 41(4):852-60. PubMed ID: 22219420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
